Setiptiline

A tetracyclic antidepressant

Setiptiline
Chemical structure of Setiptiline

Setiptiline, also known as teciptiline, is a tetracyclic antidepressant (TeCA) that was developed in the 1970s. It is primarily used in the treatment of depression and is known for its unique pharmacological profile.

Pharmacology

Setiptiline functions primarily as a noradrenergic and serotonergic agent. It acts by inhibiting the reuptake of norepinephrine and serotonin, which are neurotransmitters involved in mood regulation. This mechanism of action is similar to that of other antidepressants, but Setiptiline is distinct due to its tetracyclic structure.

Mechanism of Action

Setiptiline's antidepressant effects are believed to result from its ability to increase the levels of norepinephrine and serotonin in the brain. By preventing the reuptake of these neurotransmitters, Setiptiline enhances their activity in the central nervous system, which can help alleviate symptoms of depression.

Clinical Use

Setiptiline is prescribed for the treatment of major depressive disorder. It may be used in patients who have not responded to other antidepressants, or in those who experience side effects with other medications. The drug is typically administered orally.

Side Effects

Common side effects of Setiptiline include dry mouth, drowsiness, and dizziness. Some patients may experience weight gain or constipation. As with other antidepressants, there is a risk of suicidal thoughts in young adults and adolescents, particularly when starting the medication or adjusting the dose.

Interactions

Setiptiline can interact with other medications, particularly those that affect the central nervous system. It should be used with caution in combination with other antidepressants, antipsychotics, or benzodiazepines. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Related pages

• Antidepressant
• Tetracyclic antidepressant
• Norepinephrine
• Serotonin